You have no items in your shopping cart.
On Promotion
Category
Tested Applications
Reactivity
Conjugation
Biologically Active
Featured Product
Search results for: 'recombinant'
Biotin
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 51.5 KDa. Observed: 55-80 KDa, reducing conditions
Human
Gln33-Val237
C-Fc-Avi
20 μg, 100 μgUnconjugated
SDS-PAGE: Greater than 85% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 45.6 KDa. Observed: 45-60 KDa, reducing conditions
Human
Ser2Thr166
C-Fc
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 95.6 KDa. Observed: 120-140 KDa, reducing conditions
Human
Ser20-Thr643
C-Fc
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 17.2 KDa. Observed: 32 KDa, reducing conditions
Cynomolgus
Ala26Pro180
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 46.2 KDa. Observed: 55-70 KDa, reducing conditions
Mouse
Asp18-Thr437
C-6His
500 μg, 1 mg, 10 μg, 50 μgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 49.2 KDa. Observed: 60-80 KDa, reducing conditions
Human
Cys22-Arg221
C-Fc
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 27.8 KDa. Observed: 40-60 KDa, reducing conditions
Mouse
Gln22-Lys265
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 32.3 KDa. Observed: 32 KDa, reducing conditions
Human
Met1-Val259
N-6His
500 μg, 1 mg, 10 μg, 50 μgPredicted: 36.9&25&11.2 KDa. Observed: 37-40&26-28&14-16 KDa, reducing conditions
Human
Gln17-Ile331
C-6His
50 μg, 500 μg, 1 mg, 10 μgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 37.8 KDa. Observed: 50-70 KDa, reducing conditions
Human
Gln19-Leu353
C-6His
10 μg, 50 μg, 500 μg, 1 mg